Antibiotics Market Size 2023 | Why Asia-Pacific region dominate

The antibiotics Market Size is Anticipated To Reach 50.37 billion by 2025, witnessing a Growing CAGR of 2.1% from 2018 to 2025.
By: AMR
 
PUNE, India - Dec. 26, 2022 - PRLog -- According to the report published by Allied Market Research, The Asia-Pacific region contributed more than one-third of the total market share in 2017, owing to the burgeoning rate of antibiotics consumption, ease in availability of antibiotics, and increase in sales of antibiotics without prescription. This region would continue to dominate throughout the forecast period.

The Global Antibiotics Market Size was valued at USD 42.33 billion in 2017 and is poised to Reach USD 50.37 billion by 2025, witnessing a Growing CAGR of 2.1% from 2018 to 2025.

The key market players analyzed in the report include Abbott Laboratories, F.Hoffmann-La Roche Ltd., Allergan Plc., Merck & Co. Inc., GlaxoSmithKline plc, Novartis International AG (Sandoz), Mylan N.V., Sanofi, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. They have implemented various strategies such as expansions, mergers & acquisitions, joint ventures, partnerships, collaborations, and others to achieve a strong position in the industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5072

The beta lactam and beta lactamase inhibitors segment contributed nearly two-thirds of the total market share in 2017 and is expected to maintain its dominance by 2025. This is due to rise in demand for its effectiveness in treating Gram-positive & Gram-negative bacteria as well as use in the treatment of broad-spectrum of infections. However, quinolones segment would register the fastest CAGR of 4.3% from 2018 to 2025, owing to their characteristics such as remarkable oral bioavailability, good tissue penetration, and high broad-spectrum bactericidal activity, especially in new generation quinolones. The report also analyzes macrolides and others.

The semisynthetic segment accounted for more than one-third of the total market share in 2017 and will continue to maintain its lead by 2025. This is due to the enhanced coverage and efficacy against a wide range of organisms as well as ease in administration and cost effectiveness as compared to other antibiotics. However, the synthetic segment would register the fastest CAGR of 2.7% from 2018 to 2025 due to high demand for synthetic membrane-targeted antibiotics, broad spectrum activity, rapid bactericidal activity, no cross-resistance with existing antibiotics, and low probability of developing resistance. The report also discusses antibiotics of natural origin.

Broad-spectrum antibiotics segment contributed more than two-thirds of the total market share in 2017. This segment would dominate by 2025, registering the fastest CAGR of 2.4% from 2018 to 2025. This is attributed to the growing demand for broad-spectrum antibiotics to curb widespread antimicrobial resistance. The research also discusses narrow-spectrum antibiotics.

Get the Full Report: https://www.alliedmarketresearch.com/antibiotics-market

Contact
nikhil algoudar
***@gmail.com
End
Source:AMR
Email:***@gmail.com
Tags:Asia Pacific
Industry:Health
Location:Pune - Maharashtra - India
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Anant pvt ltd News
Trending
Most Viewed
Daily News



Like PRLog?
9K2K1K
Click to Share